202 related articles for article (PubMed ID: 30171680)
1. Treatment of Adenomyosis with Subcutaneous Etonogestrel Implants: A Clinical Observational Study in 17 Patients.
Wu J; Huang Y; Chen L; Hu J; Zou Y
Med Sci Monit; 2018 Sep; 24():6085-6092. PubMed ID: 30171680
[TBL] [Abstract][Full Text] [Related]
2. A clinical observational study on the efficacy of subcutaneous etonogestrel implants for adenomyosis in 20 patients.
Nie L; Zou H; Ma X; Cheng L; Jiao J; Wang F; Liang W; Zhang P
Gynecol Endocrinol; 2021 Aug; 37(8):735-739. PubMed ID: 34160336
[No Abstract] [Full Text] [Related]
3. Effects of Etonogestrel implants on pelvic pain and menstrual flow in women suffering from adenomyosis or endometriosis: Results from a prospective, observational study.
Niu X; Luo Q; Wang C; Zhu L; Huang L
Medicine (Baltimore); 2021 Feb; 100(6):e24597. PubMed ID: 33578561
[TBL] [Abstract][Full Text] [Related]
4. Endometriosis-associated pain scores and biomarkers in users of the etonogestrel-releasing subdermal implant or the 52-mg levonorgestrel-releasing intrauterine system for up to 24 months.
Margatho D; Carvalho NM; Bahamondes L
Eur J Contracept Reprod Health Care; 2020 Apr; 25(2):133-140. PubMed ID: 32069126
[No Abstract] [Full Text] [Related]
5. Role of levonorgestrel-releasing intrauterine system in dysmenorrhea due to adenomyosis and the influence on ovarian function.
Ji F; Yang XH; Ai Xing Zi AL; Ha Ni Ke Zi TX; He Y; Ding Y
Clin Exp Obstet Gynecol; 2014; 41(6):677-80. PubMed ID: 25566593
[TBL] [Abstract][Full Text] [Related]
6. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
Sheng J; Zhang WY; Zhang JP; Lu D
Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of gonadotropin-releasing hormone agonist and an extended-interval dosing regimen in the treatment of patients with adenomyosis and endometriosis.
Kang JL; Wang XX; Nie ML; Huang XH
Gynecol Obstet Invest; 2010; 69(2):73-7. PubMed ID: 19923847
[TBL] [Abstract][Full Text] [Related]
8. [Levonorgestrel-releasing intrauterine system for treatment of dysmenorrhea associated with adenomyosis].
Sheng J; Lu D; Zhang JP; Cui GF
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):467-70. PubMed ID: 17083813
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous etonogestrel implant combined with endometrial ablation for the treatment of adenomyosis: two case reports.
Nie LK; Zou HL; Cheng L; Zhang PH
J Obstet Gynaecol Res; 2022 Jan; 48(1):262-265. PubMed ID: 34713941
[TBL] [Abstract][Full Text] [Related]
10. Effects of different treatment methods on clinical efficacy and fertility outcomes of patients with adenomyosis.
Chu Z; Jia L; Dai J; Wu Q; Tian F; Bai S
J Ovarian Res; 2024 Jan; 17(1):16. PubMed ID: 38216945
[TBL] [Abstract][Full Text] [Related]
11. Effects of high-intensity focused ultrasound combined with levonorgestrel-releasing intrauterine system on patients with adenomyosis.
Cai Y; Sun Y; Xu F; Wu Y; Ren C; Hao X; Gao B; Cao Q
Sci Rep; 2023 Jun; 13(1):9903. PubMed ID: 37336924
[TBL] [Abstract][Full Text] [Related]
12. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.
Vercellini P; Trespidi L; Colombo A; Vendola N; Marchini M; Crosignani PG
Fertil Steril; 1993 Jul; 60(1):75-9. PubMed ID: 8513962
[TBL] [Abstract][Full Text] [Related]
13. Vaginal bromocriptine improves pain, menstrual bleeding and quality of life in women with adenomyosis: A pilot study.
Andersson JK; Khan Z; Weaver AL; Vaughan LE; Gemzell-Danielsson K; Stewart EA
Acta Obstet Gynecol Scand; 2019 Oct; 98(10):1341-1350. PubMed ID: 31025313
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of adenomyomectomy using "H" type incision combined with Mirena in the treatment of adenomyosis.
Gao Y; Shan S; Zhao X; Jiang J; Li D; Shi B
Medicine (Baltimore); 2019 Mar; 98(11):e14579. PubMed ID: 30882624
[TBL] [Abstract][Full Text] [Related]
15. Effect of Mifepristone vs Placebo for Treatment of Adenomyosis With Pain Symptoms: A Randomized Clinical Trial.
Che X; Wang J; Sun W; He J; Wang Q; Zhu D; Zhu W; Zhang J; Dong J; Xu J; Zheng F; Zhou J; Zhao W; Lin Q; Ye L; Zhao X; Xu Z; Chen Y; Wang J; Wu W; Zhai L; Zhou Y; Zheng J; Zhang X
JAMA Netw Open; 2023 Jun; 6(6):e2317860. PubMed ID: 37307001
[TBL] [Abstract][Full Text] [Related]
16. [Intermediate and long term clinical effects of uterine arterial embolization with sodium alginate microspheres in treatment of diffuse adenomyosis].
Duan P; Cheng J; Lin M; Cai LL; Hu Z; Jin SX; Hu MP
Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):272-5. PubMed ID: 18843968
[TBL] [Abstract][Full Text] [Related]
17. Transvaginal sonographic features of diffuse adenomyosis in 18-30-year-old nulligravid women without endometriosis: association with symptoms.
Pinzauti S; Lazzeri L; Tosti C; Centini G; Orlandini C; Luisi S; Zupi E; Exacoustos C; Petraglia F
Ultrasound Obstet Gynecol; 2015 Dec; 46(6):730-6. PubMed ID: 25728241
[TBL] [Abstract][Full Text] [Related]
18. Clinical application and midterm results of laparoscopic partial resection of symptomatic adenomyosis combined with uterine artery occlusion.
Kang L; Gong J; Cheng Z; Dai H; Liping H
J Minim Invasive Gynecol; 2009; 16(2):169-73. PubMed ID: 19249704
[TBL] [Abstract][Full Text] [Related]
19. Gonadotrophin-releasing hormone agonist combined with high-intensity focused ultrasound ablation for adenomyosis: a clinical study.
Guo Y; Duan H; Cheng J; Zhang Y
BJOG; 2017 Aug; 124 Suppl 3():7-11. PubMed ID: 28856862
[TBL] [Abstract][Full Text] [Related]
20. Treatment of rectovaginal endometriosis with the etonogestrel-releasing contraceptive implant.
Ferrero S; Scala C; Ciccarelli S; Vellone VG; Barra F
Gynecol Endocrinol; 2020 Jun; 36(6):540-544. PubMed ID: 31711348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
